Quanterix Corp

Industrials
Biotechnology: Laboratory Analytical Instruments
www.quanterix.com

Moat Score

Market Cap $205.26M
PE -5
Debt -
Cash $59.32M
EV -
FCF -$38.53M

Earnings

loading chart...

Sales & Net Margins

loading chart...

Earnings	-$38.53M
EBIT	-$38.10M
ROE	-12%
ROA	-9%
FCF	-$38.53M
Equity	$330.04M
Growth Stability	1
PE	-5.33
PB	0.62
P/FCF	-5.33
P/S	1.49
Price/Cash	0.29
Net Margins	-28%
Gross Margins	60%
Op. Margins	-28%
Sales Growth YoY	11%
Sales Growth QoQ	-2%
Sales CAGR	27%
Equity CAGR	40%
Earnings Growth YoY	-6%

Earnings Growth QoQ	58%
Sales CAGR 5Y	15%
Equity CAGR 5Y	14%
Earnings CAGR 3Y	9%
Sales CAGR 3Y	9%
Equity CAGR 3Y	-7%
Market Cap	$205.26M
Revenue	$137.42M
Assets	$406.53M
Cash	$59.32M
Shares Outstanding	38.37M
Moat Score	4%
Working Capital	321.59M
Current Ratio	8.66
Gross Profit	$83.10M
Shares Growth 3y	2%
Equity Growth QoQ	-3%
Equity Growth YoY	-5%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...

Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum and other fluids which are undetectable using conventional, analog immunoassay technologies. The company has developed Simoa technology which is a method of detection of proteins and has the capability of analyzing nearly six biomarkers per test, with anticipated expansion capability.

SEC Filings

Direct access to Quanterix Corp (QTRX) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

2024
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2023
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2022
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31

Sector Comparison

How does Quanterix Corp compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Quanterix Corp compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

loading chart...

Quanterix Corp Discounted Cash Flow

Fully customizable DCF calculator online for Quanterix Corp.

Years

Calculation mode

= -$385M

	0	1	2	3	4	5	6	7	8	9	10	TV
fcf	-$39M	-$39M	-$39M	-$39M	-$39M	-$39M	-$39M	-$39M	-$39M	-$39M	-$39M	-$385M
DCF		-$35M	-$32M	-$29M	-$26M	-$24M	-$22M	-$20M	-$18M	-$16M	-$15M	-$149M
Value	-$385M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years	12/2016	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	12/2024	TTM
Net Margins	-157%	-136%	-84%	-72%	-37%	-52%	-92%	-26%	-28%	-28%
ROA	-	-28%	-47%	-24%	-12%	-12%	-22%	-7%	-9%	-9%
ROE	-	-47%	-77%	-32%	-15%	-13%	-27%	-9%	-12%	-12%

Bad Net Margins (-28.04%)

Net Margins are too low to guarantee profitability in case of higher costs or higher interest rates. Furthermore lower margins cause higher earnings’ volatility.

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years	12/2016	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	12/2024	TTM
Debt over FCF	-	-0.4	-0.26	-0.21	-0.56	-	-	-	-	-
Debt over Equity	-	0.14	0.19	0.06	0.07	-	-	-	-	-
Growth Stability	-	-	-	-	-	-	-	-	-	1

Neutral Debt/FCF ratio (-)

Net Margins are at a level that is not too high nor too low. They are not a competitive advantage but they are not a competitive disadvantage either.

Neutral Debt/Equity ratio (-)

The company has a balance between equity and debt that is not too good nor too bad.

Good Graham’s Stability (1)

The company has a good stability in its earnings, which is a sign of a good competitive advantage.

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years	12/2016	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	12/2024	CAGR 5Y
Revenue YoY growth	-	30%	65%	51%	52%	28%	-5%	16%	12%	15%
Earnings YoY growth	-	13%	1%	29%	-23%	83%	68%	-67%	19%	-
Equity YoY growth	-	-157%	-38%	213%	60%	114%	-19%	-3%	-5%	14%
FCF YoY growth	-	27%	30%	22%	-26%	125%	-2%	-62%	70%	-